-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Office of the National Medical Insurance Administration and the General Office of the National Health and Health Commission issued the "Notice on Improving the Supporting Measures for the Centralized Procurement and Use of Nationally Organized Drugs (Insulin Special)"
.
The reporter learned on the 5th that the average price of the drugs selected for the insulin special project was reduced by 48%, which is expected to save a lot of medical insurance expenses
.
.
The reporter learned on the 5th that the average price of the drugs selected for the insulin special project was reduced by 48%, which is expected to save a lot of medical insurance expenses
.
It is understood that the "group purchase" of the "national team" is patient-centered, fully respects clinical choices, maintains the stability of clinical drug varieties, and reduces the risk of substitution, and a variety of insulins have been included in the scope of centralized procurement
.
Among them, Laiyoushi? and come time? As the original basal insulin, the average daily treatment cost has been reduced to less than 5 yuan, greatly improving the availability of "high-quality and affordable" drugs, which is a great news for a large number of diabetic patients in China
.
.
Among them, Laiyoushi? and come time? As the original basal insulin, the average daily treatment cost has been reduced to less than 5 yuan, greatly improving the availability of "high-quality and affordable" drugs, which is a great news for a large number of diabetic patients in China
.
In fact, the treatment rate and compliance rate of diabetes in China are still at a low level, which leads to the increase of complications, which not only seriously affects the life and quality of life of patients, but also brings a heavy burden to the national medical expenditure
.
Diabetes requires long-term management, which places higher requirements on the efficacy, safety and accessibility of medicines
.
.
Diabetes requires long-term management, which places higher requirements on the efficacy, safety and accessibility of medicines
.
Professor Zhu Dalong, chairman of the Diabetes Branch of the Chinese Medical Association, introduced: "Insulin, as an important drug for diabetic patients to control blood sugar, plays an irreplaceable role in achieving blood sugar standards
.
According to the "China Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition)", oral For patients with poor drug control, it is recommended to start using basal insulin therapy
.
As a new generation of basal insulin, Layoushi? can effectively help patients achieve stable glucose control and reduce the risk of hypoglycemia, and is more effective for the elderly and patients with renal insufficiency.
At the same time, its innovative mechanism and process enhance the patient experience in terms of injection flexibility and comfort, and further improve compliance
.
"
.
According to the "China Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition)", oral For patients with poor drug control, it is recommended to start using basal insulin therapy
.
As a new generation of basal insulin, Layoushi? can effectively help patients achieve stable glucose control and reduce the risk of hypoglycemia, and is more effective for the elderly and patients with renal insufficiency.
At the same time, its innovative mechanism and process enhance the patient experience in terms of injection flexibility and comfort, and further improve compliance
.
"
Community and county-level primary care systems are the first line of defense for chronic disease management
.
The substantial price reduction of the original basal insulin has enabled a wider range of grassroots diabetic patients to use the world's advanced therapeutic drugs, and has become an important basis for standardized diabetes management
.
Insulin "group-purchased" in the name of the "national team" will gradually arrive in the hands of patients in May
.
It is understood that patients can obtain medicines through channels such as hospitals , community pharmacies , and Internet hospitals
.
(Finish)
.
The substantial price reduction of the original basal insulin has enabled a wider range of grassroots diabetic patients to use the world's advanced therapeutic drugs, and has become an important basis for standardized diabetes management
.
Insulin "group-purchased" in the name of the "national team" will gradually arrive in the hands of patients in May
.
It is understood that patients can obtain medicines through channels such as hospitals , community pharmacies , and Internet hospitals
.
(Finish)
The Office of the National Medical Insurance Administration and the General Office of the National Health and Health Commission issued the "Notice on Improving the Supporting Measures for the Centralized Procurement and Use of Nationally Organized Drugs (Insulin Special)"
.
The reporter learned on the 5th that the average price of the drugs selected for the insulin special project was reduced by 48%, which is expected to save a lot of medical insurance expenses
.
.
The reporter learned on the 5th that the average price of the drugs selected for the insulin special project was reduced by 48%, which is expected to save a lot of medical insurance expenses
.
It is understood that the "group purchase" of the "national team" is patient-centered, fully respects clinical choices, maintains the stability of clinical drug varieties, and reduces the risk of substitution, and a variety of insulins have been included in the scope of centralized procurement
.
Among them, Laiyoushi? and come time? As the original basal insulin, the average daily treatment cost has been reduced to less than 5 yuan, greatly improving the availability of "high-quality and affordable" drugs, which is a great news for a large number of diabetic patients in China
.
.
Among them, Laiyoushi? and come time? As the original basal insulin, the average daily treatment cost has been reduced to less than 5 yuan, greatly improving the availability of "high-quality and affordable" drugs, which is a great news for a large number of diabetic patients in China
.
In fact, the treatment rate and compliance rate of diabetes in China are still at a low level, which leads to the increase of complications, which not only seriously affects the life and quality of life of patients, but also brings a heavy burden to the national medical expenditure
.
Diabetes requires long-term management, which places higher requirements on the efficacy, safety and accessibility of medicines
.
.
Diabetes requires long-term management, which places higher requirements on the efficacy, safety and accessibility of medicines
.
Professor Zhu Dalong, chairman of the Diabetes Branch of the Chinese Medical Association, introduced: "Insulin, as an important drug for diabetic patients to control blood sugar, plays an irreplaceable role in achieving blood sugar standards
.
According to the "China Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition)", oral For patients with poor drug control, it is recommended to start using basal insulin therapy
.
As a new generation of basal insulin, Layoushi? can effectively help patients achieve stable glucose control and reduce the risk of hypoglycemia, and is more effective for the elderly and patients with renal insufficiency.
At the same time, its innovative mechanism and process enhance the patient experience in terms of injection flexibility and comfort, and further improve compliance
.
"
.
According to the "China Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition)", oral For patients with poor drug control, it is recommended to start using basal insulin therapy
.
As a new generation of basal insulin, Layoushi? can effectively help patients achieve stable glucose control and reduce the risk of hypoglycemia, and is more effective for the elderly and patients with renal insufficiency.
At the same time, its innovative mechanism and process enhance the patient experience in terms of injection flexibility and comfort, and further improve compliance
.
"
Community and county-level primary care systems are the first line of defense for chronic disease management
.
The substantial price reduction of the original basal insulin has enabled a wider range of grassroots diabetic patients to use the world's advanced therapeutic drugs, and has become an important basis for standardized diabetes management
.
Insulin "group-purchased" in the name of the "national team" will gradually arrive in the hands of patients in May
.
It is understood that patients can obtain medicines through channels such as hospitals , community pharmacies , and Internet hospitals
.
(Finish)
.
The substantial price reduction of the original basal insulin has enabled a wider range of grassroots diabetic patients to use the world's advanced therapeutic drugs, and has become an important basis for standardized diabetes management
.
Insulin "group-purchased" in the name of the "national team" will gradually arrive in the hands of patients in May
.
It is understood that patients can obtain medicines through channels such as hospitals , community pharmacies , and Internet hospitals
.
(Finish)
The Office of the National Medical Insurance Administration and the General Office of the National Health and Health Commission issued the "Notice on Improving the Supporting Measures for the Centralized Procurement and Use of Nationally Organized Drugs (Insulin Special)"
.
The reporter learned on the 5th that the average price of the drugs selected for the insulin special project was reduced by 48%, which is expected to save a lot of medical insurance expenses
.
.
The reporter learned on the 5th that the average price of the drugs selected for the insulin special project was reduced by 48%, which is expected to save a lot of medical insurance expenses
.
It is understood that the "group purchase" of the "national team" is patient-centered, fully respects clinical choices, maintains the stability of clinical drug varieties, and reduces the risk of substitution, and a variety of insulins have been included in the scope of centralized procurement
.
Among them, Laiyoushi? and come time? As the original basal insulin, the average daily treatment cost has been reduced to less than 5 yuan, greatly improving the availability of "high-quality and affordable" drugs, which is a great news for a large number of diabetic patients in China
.
medicines medicines medicines.
Among them, Laiyoushi? and come time? As the original basal insulin, the average daily treatment cost has been reduced to less than 5 yuan, greatly improving the availability of "high-quality and affordable" drugs, which is a great news for a large number of diabetic patients in China
.
In fact, the treatment rate and compliance rate of diabetes in China are still at a low level, which leads to the increase of complications, which not only seriously affects the life and quality of life of patients, but also brings a heavy burden to the national medical expenditure
.
Diabetes requires long-term management, which places higher requirements on the efficacy, safety and accessibility of medicines
.
.
Diabetes requires long-term management, which places higher requirements on the efficacy, safety and accessibility of medicines
.
Professor Zhu Dalong, chairman of the Diabetes Branch of the Chinese Medical Association, introduced: "Insulin, as an important drug for diabetic patients to control blood sugar, plays an irreplaceable role in achieving blood sugar standards
.
According to the "China Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition)", oral For patients with poor drug control, it is recommended to start using basal insulin therapy
.
As a new generation of basal insulin, Layoushi? can effectively help patients achieve stable glucose control and reduce the risk of hypoglycemia, and is more effective for the elderly and patients with renal insufficiency.
At the same time, its innovative mechanism and process enhance the patient experience in terms of injection flexibility and comfort, and further improve compliance
.
"
.
According to the "China Guidelines for the Prevention and Treatment of Type 2 Diabetes (2020 Edition)", oral For patients with poor drug control, it is recommended to start using basal insulin therapy
.
As a new generation of basal insulin, Layoushi? can effectively help patients achieve stable glucose control and reduce the risk of hypoglycemia, and is more effective for the elderly and patients with renal insufficiency.
At the same time, its innovative mechanism and process enhance the patient experience in terms of injection flexibility and comfort, and further improve compliance
.
"
Community and county-level primary care systems are the first line of defense for chronic disease management
.
The substantial price reduction of the original basal insulin has enabled a wider range of grassroots diabetic patients to use the world's advanced therapeutic drugs, and has become an important basis for standardized diabetes management
.
Insulin "group-purchased" in the name of the "national team" will gradually arrive in the hands of patients in May
.
It is understood that patients can obtain medicines through channels such as hospitals , community pharmacies , and Internet hospitals
.
(Finish)
Hospital Hospital Hospital Pharmacy Pharmacy Pharmacy .
The substantial price reduction of the original basal insulin has enabled a wider range of grassroots diabetic patients to use the world's advanced therapeutic drugs, and has become an important basis for standardized diabetes management
.
Insulin "group-purchased" in the name of the "national team" will gradually arrive in the hands of patients in May
.
It is understood that patients can obtain medicines through channels such as hospitals , community pharmacies , and Internet hospitals
.
(Finish)
